Assessment of the use of adrenaline auto-injectors among a logia bez u i 1 adult patients at risk of anaphylaxis

Basit Öğe Kaydı
dc.authorwosidÖzdemir, Ebru/HGF-0700-2022
dc.contributor.authorOzdemir, Ebru
dc.contributor.authorDamadoglu, Ebru
dc.contributor.authorKarakaya, Gul
dc.contributor.authorKalyoncu, Ali
dc.date.accessioned2024-08-04T20:57:12Z
dc.date.available2024-08-04T20:57:12Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractIntroduction: Carriage and correct use of adrenaline auto-injectors (AAIs) by patients have been reported to be low. Aim: To evaluate the carriage rate of the EpiPen degrees and the usage skills of the adult patients. Material and methods: A total of 46 patients who had been previously prescribed EpiPen degrees were enrolled during a five-month period in our clinic. Data about the EpiPen degrees prescription indications and prescription date, the number of the device usage training sessions, the last training date, and the reasons for not carrying the device were obtained. Patients were practically evaluated with a trainer device. Results: Among 46 patients, 20 (43%) were female, and the mean age of the patients was 45 +/- 13 years (min.-max.: 20-67). EpiPen degrees prescription indication included Hymenoptera venom allergy in 44 patients, food allergy in one patient, and idiopathic anaphylaxis in one patient. Twenty-nine (63%) patients reported that they kept the device with them always, whereas 17 (37%) reported they did not. The most frequently stated reason for not carrying an EpiPen degrees was the thought that it was unnecessary (n = 6, 35%). Of 29 patients, 11 (38%) correctly demonstrated all the steps of the trainer device. The most frequent mistake was failing to remove the cap (n = 15, 83%). Conclusions: The significance of always carrying the device at all times should be emphasized, as should the importance of correct use of the device in patients' routine controls. Trainings given at least twice a year may be supported by reminders via telephone call or e-mail.en_US
dc.identifier.doi10.5114/pja.2022.119231
dc.identifier.endpage190en_US
dc.identifier.issn2353-3854
dc.identifier.issue3en_US
dc.identifier.startpage186en_US
dc.identifier.urihttps://doi.org/10.5114/pja.2022.119231
dc.identifier.urihttps://hdl.handle.net/11616/102424
dc.identifier.volume9en_US
dc.identifier.wosWOS:000901823300005en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherTermedia Publishing House Ltden_US
dc.relation.ispartofAlergologia Polska-Polish Journal of Allergologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectadrenaline auto-injectorsen_US
dc.subjecttrainingen_US
dc.subjectcarriageen_US
dc.subjectanaphylaxisen_US
dc.titleAssessment of the use of adrenaline auto-injectors among a logia bez u i 1 adult patients at risk of anaphylaxisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu